Chapman & Hall/CRC biostatistics series

• 資料種別: 図書
• タイトル: Chapman & Hall/CRC biostatistics series
• 出版事項: Chapman & Hall/CRC
• 出版地（国名コード）: us
• 対象利用者: 一般
• 一般注記: Publisher varies: CRC Press
• 関連情報: Statistical methods for immunogenicity assessment; https://cir.nii.ac.jp/crid/1130000793684890880; Bayesian analysis made simple : an Excel GUI for WinBUGS; https://cir.nii.ac.jp/crid/1130000793714518656; Randomized phase II cancer clinical trials; https://cir.nii.ac.jp/crid/1130000793730235136; Essentials of a successful biostatistical collaboration; https://cir.nii.ac.jp/crid/1130000793797741056; Randomized clinical trials of nonpharmacological treatments; https://cir.nii.ac.jp/crid/1130000793870701824; Repeated measures design with generalized linear mixed models for randomized controlled trials; https://cir.nii.ac.jp/crid/1130000793994652032; Data and safety monitoring committees in clinical trials; https://cir.nii.ac.jp/crid/1130000794175237632; Frailty models in survival analysis; https://cir.nii.ac.jp/crid/1130000794211396480; Noninferiority testing in clinical trials : issues and challenges; https://cir.nii.ac.jp/crid/1130000794222461952; Adaptive designs for sequential treatment allocation; https://cir.nii.ac.jp/crid/1130000794362187264; Statistical approaches in oncology clinical development : current paradigm and methodological advancement; https://cir.nii.ac.jp/crid/1130000794430459136; Data analysis with competing risks and intermediate states; https://cir.nii.ac.jp/crid/1130000794623409152; Adaptive design methods in clinical trials; https://cir.nii.ac.jp/crid/1130000794674363264; Biostatistics : a computing approach; https://cir.nii.ac.jp/crid/1130000794966543360; Design and analysis of clinical trials for predictive medicine; https://cir.nii.ac.jp/crid/1130000794985106944; Bayesian methods in epidemiology; https://cir.nii.ac.jp/crid/1130000795018257536; Sample size calculations in clinical research; https://cir.nii.ac.jp/crid/1130000795205838080; Design and analysis of non-inferiority trials; https://cir.nii.ac.jp/crid/1130000795347360000; Design and analysis of bioavailability and bioequivalence studies; https://cir.nii.ac.jp/crid/1130000795585989248; Adaptive design theory and implementation using SAS and R; https://cir.nii.ac.jp/crid/1130000795626723328; Quantitative evaluation of safety in drug development : design, analysis and reporting; https://cir.nii.ac.jp/crid/1130000795657062016; Applied surrogate endpoint evaluation methods with SAS and R; https://cir.nii.ac.jp/crid/1130000795780370432; Bayesian methods in health economics; https://cir.nii.ac.jp/crid/1130000795788537344; Bayesian methods for measures of agreement; https://cir.nii.ac.jp/crid/1130000795834079616; Randomization, masking, and allocation concealment; https://cir.nii.ac.jp/crid/1130000795989637760; Sample size calculations for clustered and longitudinal outcomes in clinical research; https://cir.nii.ac.jp/crid/1130000796029414912; Medical biostatistics; https://cir.nii.ac.jp/crid/1130000796120567680; Elementary bayesian biostatistics; https://cir.nii.ac.jp/crid/1130000796208190080; Design and analysis of clinical trials with time-to-event endpoints; https://cir.nii.ac.jp/crid/1130000796335945216; Benefit-risk assessment in pharmaceutical research and development; https://cir.nii.ac.jp/crid/1130000796336450688; Clinical trial methodology; https://cir.nii.ac.jp/crid/1130000796404147072; https://cir.nii.ac.jp/crid/1130000796771992192; Bayesian adaptive methods for clinical trials; https://cir.nii.ac.jp/crid/1130000796958974848; Measures of interobserver agreement and reliability; https://cir.nii.ac.jp/crid/1130000797023219968; Patient-reported outcomes : measurement, implementation and interpretation; https://cir.nii.ac.jp/crid/1130000797074481280; Optimal design for nonlinear response models; https://cir.nii.ac.jp/crid/1130000797280308480; Benefit-risk assessment methods in medical product development : bridging qualitative and quantitative assessments; https://cir.nii.ac.jp/crid/1130000797672054144; Bioequivalence and statistics in clinical pharmacology; https://cir.nii.ac.jp/crid/1130000797772063360; Clinical and statistical considerations in personalized medicine; https://cir.nii.ac.jp/crid/1130000797904227200; Statistical evaluation of diagnostic performance : topics in ROC analysis; https://cir.nii.ac.jp/crid/1130000797905048832; Platform trial designs in drug development : umbrella trials and basket trials; https://cir.nii.ac.jp/crid/1130000798041556736; https://cir.nii.ac.jp/crid/1130000798086619520; Clinical trial data analysis using R and SAS; https://cir.nii.ac.jp/crid/1130000798114299264; Modeling to inform infectious disease control; https://cir.nii.ac.jp/crid/1130000798242983936; Monte Carlo simulation for the pharmaceutical industry : concepts, algorithms, and case studies; https://cir.nii.ac.jp/crid/1130003901342876032; Innovative Statistics in regulatory science; https://cir.nii.ac.jp/crid/1130003902842533760; Estimands, estimators and sensitivity analysis in clinical trials; https://cir.nii.ac.jp/crid/1130003903653229952; Bayesian methods in pharmaceutical research; https://cir.nii.ac.jp/crid/1130004957806900864; Applied meta-analysis with R and Stata; https://cir.nii.ac.jp/crid/1130006882940567964; Medical risk prediction models : with ties to machine learning; https://cir.nii.ac.jp/crid/1130007425116329357; Economic evaluation of cancer drugs : using clinical trial and real-world data; https://cir.nii.ac.jp/crid/1130010301316975240; https://cir.nii.ac.jp/crid/1130010831740065028; Statistical thinking in clinical trials; https://cir.nii.ac.jp/crid/1130011838007309210; Bayesian analysis of infectious diseases : COVID-19 and beyond; https://cir.nii.ac.jp/crid/1130013154766144916; Statistical analytics for health data science with SAS and R; https://cir.nii.ac.jp/crid/1130014171865531395; Self-controlled case series studies : a modelling guide with R; https://cir.nii.ac.jp/crid/1130282268728258432; Statistical methods for survival trial design : with applications to cancer clinical trials using R; https://cir.nii.ac.jp/crid/1130282268763389056; Advanced Bayesian methods for medical test accuracy; https://cir.nii.ac.jp/crid/1130282268887740800; Bayesian designs for phase I-II clinical trials; https://cir.nii.ac.jp/crid/1130282269036304000; Cancer clinical trials : current and controversial issues in design and analysis; https://cir.nii.ac.jp/crid/1130282269046118784; DNA methylation microarrays : experimental design and statistical analysis; https://cir.nii.ac.jp/crid/1130282269143420032; Statistical design and analysis of clinical trials : principles and methods; https://cir.nii.ac.jp/crid/1130282269173747840; Introductory adaptive trial designs : a practical guide with R; https://cir.nii.ac.jp/crid/1130282269253324800; Bayesian modeling in bioinformatics; https://cir.nii.ac.jp/crid/1130282269472873600; https://cir.nii.ac.jp/crid/1130282269592840192; Interval-censored time-to-event data : methods and applications; https://cir.nii.ac.jp/crid/1130282269941093888; Bayesian cost-effectiveness analysis of medical treatments; https://cir.nii.ac.jp/crid/1130282270013962624; Joint models for longitudinal and time-to-event data : with applications in R; https://cir.nii.ac.jp/crid/1130282270198897536; Analyzing longitudinal clinical trial data : a practical guide; https://cir.nii.ac.jp/crid/1130282270254669568; Empirical likelihood method in survival analysis; https://cir.nii.ac.jp/crid/1130282270474989440; Statistical methods in drug combination studies; https://cir.nii.ac.jp/crid/1130282270637228800; Clinical trial optimization using R; https://cir.nii.ac.jp/crid/1130282270777017344; Multiple testing problems in pharmaceutical statistics; https://cir.nii.ac.jp/crid/1130282270806444672; Applied meta-analysis with R; https://cir.nii.ac.jp/crid/1130282271020814976; Quantitative methods for HIV/AIDS research; https://cir.nii.ac.jp/crid/1130282271058848768; https://cir.nii.ac.jp/crid/1130282271100284160; Statistical topics in health economics and outcomes research; https://cir.nii.ac.jp/crid/1130282271287133696; Translational medicine : strategies and statistical methods; https://cir.nii.ac.jp/crid/1130282271346087808; Bayesian missing data problems : EM, data augmentation and noniterative computation; https://cir.nii.ac.jp/crid/1130282271428155008; Innovative strategies, statistical solutions and simulations for modern clinical trials; https://cir.nii.ac.jp/crid/1130282271476889472; Confidence intervals for proportions and related measures of effect size; https://cir.nii.ac.jp/crid/1130282271631067264; Cluster randomised trials; https://cir.nii.ac.jp/crid/1130282271705502976; Bayesian methods for repeated measures; https://cir.nii.ac.jp/crid/1130282271811728384; Statistical methods for drug safety; https://cir.nii.ac.jp/crid/1130282271995611520; Medical product safety evaluation : biological models and statistical methods; https://cir.nii.ac.jp/crid/1130282272115422848; Methods in comparative effectiveness research; https://cir.nii.ac.jp/crid/1130282272132324352; https://cir.nii.ac.jp/crid/1130282272201814144; Dynamical biostatistical models; https://cir.nii.ac.jp/crid/1130282272305721344; Multiregional clinical trials for simultaneous global new drug development; https://cir.nii.ac.jp/crid/1130282272366637824; https://cir.nii.ac.jp/crid/1130282272368381184; Fundamental concepts for new clinical trialists; https://cir.nii.ac.jp/crid/1130282272426658816; https://cir.nii.ac.jp/crid/1130282272560025472; Modern adaptive randomized clinical trials : statistical and practical aspects; https://cir.nii.ac.jp/crid/1130282272704780928; Computational methods in biomedical research; https://cir.nii.ac.jp/crid/1130282272887767296; Clinical trial data analysis using R; https://cir.nii.ac.jp/crid/1130282273101788672; https://cir.nii.ac.jp/crid/1130285377554947712; https://cir.nii.ac.jp/crid/1130291080101764233; https://cir.nii.ac.jp/crid/1130293003789846533; Statistical methods in health disparity research; https://cir.nii.ac.jp/crid/1130299429151833093; Artificial intelligence for drug development, precision medicine, and healthcare; https://cir.nii.ac.jp/crid/1130567904673781120; Biomarker analysis in clinical trials with R; https://cir.nii.ac.jp/crid/1130567907379603072; Geospatial health data : modeling and visualization with R-INLA and Shiny; https://cir.nii.ac.jp/crid/1130567907761877376; Real-world evidence in drug development and evaluation; https://cir.nii.ac.jp/crid/1130570375040572177; Advanced survival models; https://cir.nii.ac.jp/crid/1130571149336166550; Cure models : methods, applications, and implementation; https://cir.nii.ac.jp/crid/1130575020489309210; Analysis of incidence rates; https://cir.nii.ac.jp/crid/1130848328731778304; Structural equation modeling for health and medicine; https://cir.nii.ac.jp/crid/1130850998145351055; Real-world evidence in a patient-centric digital era; https://cir.nii.ac.jp/crid/1130856495692991262; https://cir.nii.ac.jp/crid/1130856650889091477; https://cir.nii.ac.jp/crid/1130858596794726528; https://cir.nii.ac.jp/crid/1130858596794816175; Data science, AI, and machine learning in drug development; https://cir.nii.ac.jp/crid/1130858818733353349; Statistical methods for mediation, confounding and moderation analysis using R and SAS; https://cir.nii.ac.jp/crid/1130861294946769152; Bayesian applications in pharmaceutical development; https://cir.nii.ac.jp/crid/1131693807667297280
• 関連情報（URI）: https://ci.nii.ac.jp/ncid/BA8313747X#entity
• 連携機関・データベース: 国立情報学研究所 : CiNii Research
• 提供元機関・データベース: CiNii Books; https://ci.nii.ac.jp/books
• NACSIS書誌ID（NCID）: https://ci.nii.ac.jp/ncid/BA8313747X : BA8313747X

目次

Statistical methods for immunogenicity assessment

Bayesian analysis made simple : an Excel GUI for WinBUGS

Randomized phase II cancer clinical trials

Essentials of a successful biostatistical collaboration

Randomized clinical trials of nonpharmacological treatments